Immunic AG
IMUX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US4525EP1011
- LEI:
- 549300R5T12FW5MEQB20
- Country:
- United States of America
- Address:
- C/O The Corporation Trust Company, 19801 Wilmington
- Website:
- https://imux.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-07 12:30 |
Earnings Release
Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corpor…
|
English | 23.5 KB | |
| 2025-06-24 12:30 |
Regulatory News Service
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 …
|
English | 15.2 KB | |
| 2025-06-05 12:30 |
Earnings Release
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Re…
|
English | 18.3 KB | |
| 2025-06-02 12:30 |
Regulatory News Service
Immunic to Participate in Investor, Scientific and Industry Conferences in June
|
English | 13.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |